Assembly Biosciences (ASMB) EPS (Basic) (2010 - 2026)
Assembly Biosciences' (ASMB) quarterly EPS (Basic) came in at -$0.69 in Q1 2026, up 47.96% year-on-year from -$0.47 in Q1 2025, and down 135.13% quarter-over-quarter from $1.97 in Q4 2025.
Assembly Biosciences (ASMB) EPS (Basic) (2010 - 2026) Analysis & Trends
Assembly Biosciences' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.69 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 47.96% year-over-year to -$0.69 in Q1 2026; TTM through Mar 2026 was -$0.53, a 90.27% increase from a year earlier, with the FY2025 full-year figure at -$0.55, up 91.84% from the prior year.
- EPS (Basic) retreated to -$0.69 in Q1 2026 per ASMB's latest filing, from $1.97 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.97 in Q4 2025 and bottomed at -$6.14 in Q2 2022.
- The 5-year median for EPS (Basic) is -$1.98 (2024), against an average of -$2.75.
- Across the five-year window, EPS (Basic) increased 10.91% in 2022 and surged 214.48% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$5.99 in 2022, then surged by 60.0% to -$2.39 in 2023, then advanced by 28.13% to -$1.72 in 2024, then jumped by 214.48% to $1.97 in 2025, then slumped by 135.13% to -$0.69 in 2026.
- Per Business Quant, the three latest ASMB EPS (Basic) figures stand at -$0.69 (Q1 2026), $1.97 (Q4 2025), and -$0.72 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | -0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69 |
| Dec 31, 2025 | 1.97 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | -1.33 |
| Mar 31, 2025 | -1.33 |
| Dec 31, 2024 | -1.72 |
| Sep 30, 2024 | -1.51 |
| Jun 30, 2024 | -1.98 |
| Mar 31, 2024 | -1.66 |
| Dec 31, 2023 | -2.39 |
| Sep 30, 2023 | -3.29 |
| Jun 30, 2023 | -3.88 |
| Mar 31, 2023 | -4.53 |
| Dec 31, 2022 | -5.99 |
| Sep 30, 2022 | -5.80 |
| Jun 30, 2022 | -6.14 |
| Mar 31, 2022 | -5.80 |
| Dec 31, 2021 | -17.67 |
| Sep 30, 2021 | -7.10 |
| Jun 30, 2021 | -6.89 |